Worth reading
44Recurring
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses)
発行済株式総数
Exercise ratio for the month: 0.00% for the 8th series and 0.00% for the 9th series. Exercise ratio subject to exercise restrictions: 0%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥2,757 for the 8th series and ¥3,192 for the 9th series. Whether adjustment clauses apply and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total number issued: Not disclosed. Number exercised during the month under review: 0 for the 8th series and 0 for the 9th series. Remaining unexercised rights at month-end: 2,340 for the 8th series (234,000 shares) and 727 for the 9th series (72,700 shares)
Procedures under the Corporate Code of Conduct
Report on compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Timing 7 April 2022 / Type 8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | 8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses) |
| Dilution Rate | Exercise ratio for the month: 0.00% for the 8th series and 0.00% for the 9th series. Exercise ratio subject to exercise restrictions: 0% |
| Total number of issued shares | 2,762,100 shares (as of the end of the month preceding the month under review, including 73,766 treasury shares) → 2,762,100 shares (estimated to be as of the end of the month under review; the document does not state the month-end number of issued shares) |
| Exercise price | ¥2,757 for the 8th series and ¥3,192 for the 9th series. Whether adjustment clauses apply and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed. Number exercised during the month under review: 0 for the 8th series and 0 for the 9th series. Remaining unexercised rights at month-end: 2,340 for the 8th series (234,000 shares) and 727 for the 9th series (72,700 shares) |
| Procedures under the Corporate Code of Conduct | Report on compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Timing 7 April 2022 / Type 8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses) / Amount Not disclosed |
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is a report on the monthly exercise status, and no reason was stated for the rights not being exercised.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.